These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 15634544)
1. [Clinical study of hemostatic molecular markers expression in patients with cancer]. Wu F; Qu B; Wang XF; Yang CM; Wang HL Zhonghua Nei Ke Za Zhi; 2004 Nov; 43(11):837-40. PubMed ID: 15634544 [TBL] [Abstract][Full Text] [Related]
2. Clinical significance of plasma tissue factor pathway and urokinase-type plasminogen activator system in cancer patients. Zhao W; Wang X; Qu B; Huang X; Wang H Chin Med J (Engl); 2002 May; 115(5):702-4. PubMed ID: 12133538 [TBL] [Abstract][Full Text] [Related]
3. [Study of the effect of TF/FVIIa complex on the expression of u-PAR mRNA in human ovarian cancer]. Fang J; Wei WN; Xia LH; Song SJ Zhonghua Xue Ye Xue Za Zhi; 2004 Mar; 25(3):143-6. PubMed ID: 15182581 [TBL] [Abstract][Full Text] [Related]
4. [A study of tissue factor expression and hemostatic molecular markers in patients with acute promyelocytic leukemia]. Wu F; Wang X; Zhao W; Wang H; Shen Z Zhonghua Nei Ke Za Zhi; 2001 Jan; 40(1):36-9. PubMed ID: 11798557 [TBL] [Abstract][Full Text] [Related]
5. Expression of urokinase-type plasminogen activator (u-PA), u-PA receptor, and tissue-type PA messenger RNAs in human hepatocellular carcinoma. De Petro G; Tavian D; Copeta A; Portolani N; Giulini SM; Barlati S Cancer Res; 1998 May; 58(10):2234-9. PubMed ID: 9605771 [TBL] [Abstract][Full Text] [Related]
6. Urokinase system expression in gastric carcinoma: prognostic impact in an independent patient series and first evidence of predictive value in preoperative biopsy and intestinal metaplasia specimens. Beyer BC; Heiss MM; Simon EH; Gruetzner KU; Babic R; Jauch KW; Schildberg FW; Allgayer H Cancer; 2006 Mar; 106(5):1026-35. PubMed ID: 16435385 [TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro expression of the plasminogen activators and urokinase type plasminogen activator receptor (u-PAR) in the pig oviduct. Roldán-Olarte M; García DC; Jiménez-Díaz M; Valdecantos PA; Miceli DC Anim Reprod Sci; 2012 Dec; 136(1-2):90-9. PubMed ID: 23103014 [TBL] [Abstract][Full Text] [Related]
8. [Expression and clinical significance of coagulate and fibrolysis factors in tissue and plasma from hepatocellular carcinoma patients]. Zhou Q; Liang LJ; Peng BG; Zhen YY Ai Zheng; 2006 Nov; 25(11):1433-8. PubMed ID: 17094916 [TBL] [Abstract][Full Text] [Related]
9. Relationship between urokinase-type plasminogen receptor, interleukin-8 gene expression and clinicopathological features in gastric cancer. Lee KH; Bae SH; Lee JL; Hyun MS; Kim SH; Song SK; Kim HS Oncology; 2004; 66(3):210-7. PubMed ID: 15218312 [TBL] [Abstract][Full Text] [Related]
10. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells. Tabengwa EM; Grenett HE; Benza RL; Abou-Agag LH; Tresnak JK; Wheeler CG; Booyse FM Alcohol Clin Exp Res; 2001 Feb; 25(2):163-70. PubMed ID: 11236828 [TBL] [Abstract][Full Text] [Related]
11. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori. Iwamoto J; Mizokami Y; Takahashi K; Nakajima K; Ohtsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Takehara H; Matsuoka T Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653 [TBL] [Abstract][Full Text] [Related]
12. Effect of oxidative stress on the expression of t-PA, u-PA, u-PAR, and PAI-1 in endothelial cells. Oszajca K; Bieniasz M; Brown G; Swiatkowska M; Bartkowiak J; Szemraj J Biochem Cell Biol; 2008 Dec; 86(6):477-86. PubMed ID: 19088796 [TBL] [Abstract][Full Text] [Related]
13. Effects of all-trans-retinoic acid and arsenic trioxide on the hemostatic disturbance associated with acute promyelocytic leukemia. Zhao W; Wang H; Wang X; Wu F; Guo W; Qu B; Shen Z; Wang Z Thromb Res; 2001 May; 102(3):197-204. PubMed ID: 11369412 [TBL] [Abstract][Full Text] [Related]
14. The Clinical Study of Urokinase-Type Plasminogen Activator and Vascular Endothelial Growth Factor in Gastric Cancer. Yang XW; Gao F; Chen YJ; Teng FM Cell Biochem Biophys; 2015 Jul; 72(3):649-52. PubMed ID: 27352182 [TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of hemostatic molecular markers in acute leukemia]. Wu F; Wang X; Qu B; Huang X; Wang H Zhonghua Xue Ye Xue Za Zhi; 2001 Mar; 22(3):141-4. PubMed ID: 11877066 [TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of urokinase-type plasminogen activator (PA), PA inhibitor type-1, and tissue-type PA antigen levels in node-negative breast cancer: a prospective study on multicenter basis. Kim SJ; Shiba E; Kobayashi T; Yayoi E; Furukawa J; Takatsuka Y; Shin E; Koyama H; Inaji H; Takai S Clin Cancer Res; 1998 Jan; 4(1):177-82. PubMed ID: 9516968 [TBL] [Abstract][Full Text] [Related]
17. Cellular distribution and clinical value of urokinase-type plasminogen activator, its receptor, and plasminogen activator inhibitor-2 in esophageal squamous cell carcinoma. Shiomi H; Eguchi Y; Tani T; Kodama M; Hattori T Am J Pathol; 2000 Feb; 156(2):567-75. PubMed ID: 10666386 [TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of tissue- and urokinase-type plasminogen activator genes by thrombin in human fetal lung fibroblasts. Hayakawa Y; Tazawa S; Ishikawa T; Niiya K; Sakuragawa N Thromb Haemost; 1995 Aug; 74(2):704-10. PubMed ID: 8585010 [TBL] [Abstract][Full Text] [Related]
19. Tissue plasminogen activator and urokinase plasminogen activator in human epileptogenic pathologies. Iyer AM; Zurolo E; Boer K; Baayen JC; Giangaspero F; Arcella A; Di Gennaro GC; Esposito V; Spliet WG; van Rijen PC; Troost D; Gorter JA; Aronica E Neuroscience; 2010 May; 167(3):929-45. PubMed ID: 20219643 [TBL] [Abstract][Full Text] [Related]
20. The kidneys of mice with autoimmune disease acquire a hypofibrinolytic/procoagulant state that correlates with the development of glomerulonephritis and tissue microthrombosis. Yamamoto K; Loskutoff DJ Am J Pathol; 1997 Sep; 151(3):725-34. PubMed ID: 9284821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]